Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely?

Published:2011-08 Issue:2 Volume:60 Page:223-225
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Roobol Monique J.

Publisher

Elsevier BV

Subject

Urology

Reference12 articles.

1. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study;Schröder;N Engl J Med,2009

2. Prostate cancer mortality reduction by prostate-specific antigen–based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC);Roobol;Eur Urol,2009

3. Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam);Kerkhof;Int J Cancer,2010

4. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial;Hugosson;Lancet Oncol,2010

5. Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer;Heijnsdijk;Br J Cancer,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic value of prostate-specific antigen according to age patients;Urologicheskie vedomosti;2016-09-15

2. Prostate cancer: ESMO Consensus Conference Guidelines 2012;Annals of Oncology;2013-05

3. Risk stratification in prostate cancer screening;Nature Reviews Urology;2012-12-18

4. Diagnosis, Clinical Work Up, TNM Classification, Markers;Management of Prostate Cancer;2012

5. Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223–5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction. Eur Urol 2011;60:226–8;European Urology;2011-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3